Spain Breast Pump Market Report

Spain Breast Pump Market Executive Summary

The Spain Breast Pump Market is at around $56.7 Mn in 2023 and is projected to reach $94.8 Mn in 2030, exhibiting a CAGR of 7.6% during the forecast period.

A breast pump is a mechanical device that lactating women use to extract milk from their breasts. They are available in two forms; they can be manual devices powered by hand or foot movements or automatic devices powered by electricity. Breast pumps are available in a variety of styles to meet the demands of moms. Hand-operated manual pumps are lightweight and silent, making them ideal for sporadic usage. Electric pumps are often used on a regular basis because of their higher efficiency and ability to run on mains or batteries. There are several uses for breast pumps. Many parents use them to continue breastfeeding after they return to work. They express their milk at work, which is later bottle-fed to their child by a caregiver. A breast pump may also be used to address a range of challenges parents may encounter during breastfeeding, including difficulties latching, separation from an infant in intensive care, feeding an infant who cannot extract sufficient milk itself from the breast, to avoid passing medication through breast milk to the baby, or to relieve engorgement, which is a painful condition whereby the breasts are overfull.

The Spain Breast Pump Market is driven by significant factors such as the rising female workforce, enhanced features, and consumer awareness. However, stringent regulations, physical discomfort, and societal judgments about breast pumps restrict the growth and potential of the market.

The major players in the Spain Breast Pump Market are Medela, Elvie, Ameda, Avent, and Evenflo, among others.

Market Dynamics

Market Growth Drivers

Rising Female Workforce: In Spain, where female labor force participation reached 52.6% in 2023, the increasing presence of women in the professional sector drives breast pump market growth. As more women advance in their careers, the demand for solutions that balance work and family life rises. Breast pumps provide convenience and flexibility for working mothers, supported by progressive workplace policies and growing breastfeeding awareness, leading to higher adoption rates and substantial market expansion.

Enhanced Features: In Spain, the breast pump market is growing due to advanced features like portability, customizable suction levels, quiet operation, and smart technology. Innovations such as wearable designs and smartphone connectivity cater to busy mothers, enhancing flexibility and efficiency. These advancements make premium breast pumps more appealing, driving market expansion.

Consumer Awareness: In Spain, growing consumer awareness about breast pumps is a key factor driving market expansion. As understanding of the benefits of breastfeeding and the advantages of modern breast pump technologies increases, more parents are opting for these devices to meet their breastfeeding goals. Educational campaigns, health seminars, and endorsements from healthcare professionals have enhanced knowledge of how breast pumps can aid breastfeeding, enhance milk production, and offer flexibility for working mothers. This heightened awareness boosts consumer confidence and stimulates demand, thereby fostering growth in the Breast Pump Market.

Market Restraints

Stringent Regulations: Stringent regulations governing medical devices in Spain act as a significant restraint on the growth of the breast pump market. These strict regulatory requirements can delay the introduction of new products to the market, increase compliance costs, and create barriers for manufacturers seeking to innovate. As a result, companies face challenges in meeting regulatory standards, leading to a slower rate of product approval and market entry. This, in turn, hampers the availability of advanced breast pump technologies and can limit market expansion, making it difficult for manufacturers to respond swiftly to consumer demand and evolving market trends.

Physical Discomfort: In Spain, the discomfort caused by prolonged use of breast pumps can impede market growth by deterring potential users and reducing overall satisfaction. Many women experience pain, irritation, or an improper fit with breast pump components, making extended use uncomfortable and difficult. This discomfort can result in decreased usage, discouraging new mothers from purchasing or consistently using breast pumps. Consequently, these issues can negatively affect the growth of the breast pump market.

Societal Judgements: In Spain, societal attitudes towards breast pumps can restrict market growth due to ongoing stigmas and cultural perceptions. Misunderstandings about the necessity and appropriateness of breast pumps may result in limited acceptance among certain demographics. Traditional views on breastfeeding often make breast pumps appear less favorable compared to direct breastfeeding, and societal expectations to breastfeed exclusively without pumps influence purchasing choices. These cultural and social views can affect the overall demand for breast pumps, thereby limiting market expansion.

Regulatory Landscape and Reimbursement Scenario

The regulatory body for pharmaceuticals in Spain is the Spanish Agency of Medicines and Medical Devices (AEMPS, Agencia Española de Medicamentos y Productos Sanitarios) which operates under the Ministry of Health, Social Services, and Equality. AEMPS plays a critical role in safeguarding public health in Spain by ensuring the efficacy, safety, and quality of pharmaceuticals, including both human and veterinary medications. For novel medications meant for the Spanish market, AEMPS evaluates applications and issues marketing authorizations. They also oversee the lifecycle of drugs that have previously received approval.

The pharmaceutical companies must submit a completed MAA (Marketing Authorization Application) which can be used for drugs meant for the Spain market (National Procedure) or for the drugs intended for commercialization throughout the European Union (EU) through the EMA (European Medicines Agency). Through the EMA, products can be authorized through the National Procedure, the Centralised Procedure (CP), the Decentralised Procedure (DCP), or the Mutual Recognition Procedure (MRP). In this case, AEMPS acts as a national competent authority (NCA) within the EMA framework. It then issues a final decision of either approval, conditional approval, or refusal after conducting a review and evaluation of the MAA based on safety, efficacy, quality, and risk-benefit ratio. Even after entering the market, AEMPS and other stakeholders continue to monitor the drug’s safety profile through pharmacovigilance by gathering and examining adverse reaction data.

In Spain, the Ministry of Health (MOH) is the department of the central government responsible for approving reimbursement of medicinal products. When AEMPS grants final authorization for the packaging materials to be used in Spain, the process of pricing and reimbursement for a centrally approved pharmaceutical product starts. After AEMPS has given its approval for the product’s final packaging, it will document this decision and notify the MAH as well as the General Directorate for Pharmacy and Medical Devices, which is the body within the MOH competent to decide on reimbursement. The central government is the primary decision-maker in the reimbursement process. The MOH determines price and reimbursement after consulting with the ICPM and the General Directorate for Pharmacy and Medical Devices. The maximum amount that can be paid is determined by the ICPM after the General Directorate for Pharmacy and Medical Devices makes the initial decision about the product's reimbursement status.

Competitive Landscape

Key Players

Here are some of the major key players in the Spain Breast Pump Market:

• Medela
• Elvie
• Ameda
• Avent
• Evenflo
• Hygeia
• Willow
• Perifit
• Kimetech GmbH
• Horigen